WordNet

a nucleoside that is formed by the deamination of adenosine; used in kidney transplantation to provide a temporary source of sugar

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/06/17 01:24:00」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. リウマチ性疾患に対する補完・代替療法 complementary and alternative remedies for rheumatic disorders
2. プリオンによる中枢神経系疾患 diseases of the central nervous system caused by prions

Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature.

Colpak AI, Erdener SE, Ozgen B, Anlar B, Kansu T.SourceNeuro-Ophthalmology Unit, Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey.
Current opinion in ophthalmology.Curr Opin Ophthalmol.2012 Nov;23(6):466-71. doi: 10.1097/ICU.0b013e328358b196.
PURPOSE OF REVIEW: To review the literature on early visual manifestations of subacute sclerosing panencephalitis (SSPE) with regard to two patients who had visual problems preceding the onset of neurological symptoms. One patient had cortical visual disturbances and the other had visual loss due to
PMID 23047165

Psychomotor development after ganciclovir selectively treated congenital and perinatal cytomegalovirus infection.

Ivanov IS, Popov NT, Moshe RI, Chepisheva EV, Geneva IE, Panova MV, Karparov AA, Shmilev TI, Stefanov RS, Bosheva MN.SourceDepartment of Pediatrics and Medical Genetics, Medical University, Plovdiv, Bulgaria. ivanovist@gmail.com
Folia medica.Folia Med (Plovdiv).2012 Oct-Dec;54(4):37-44.
AIM: To study the development of children with selectively treated cytomegalovirus infection.PATIENTS AND METHODS: We studied prospectively a risk group of 12 children with cytomegalovirus infection. These children were diagnosed by serological screening in the first three months after birth and are
PMID 23441468

[Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas].

Iakupova RSh, Skachkova MA, Choloian SB, Karpova EG.AbstractThe authors evaluated the clinical efficacy and safety of the antiviral and immunomodulatory drug Isoprinosine (inosine pranobex, Teva Pharmaceutical Industries, Ltd) in the treatment of bronchopulmonary diseases in children. One hundred and fifty-two children with acute respiratory diseases and an exacerbation of recurrent respiratory diseases were followed up. The use of Isoprinosine in their combined treatment showed both positive clinical changes and a better immunogram.
Gigiena i sanitariia.Gig Sanit.2012 May-Jun;(3):33-4.
The authors evaluated the clinical efficacy and safety of the antiviral and immunomodulatory drug Isoprinosine (inosine pranobex, Teva Pharmaceutical Industries, Ltd) in the treatment of bronchopulmonary diseases in children. One hundred and fifty-two children with acute respiratory diseases and an
PMID 23088120

リンク元	「イノシンプラノベクス」「イノシンプラノベクス」「Isoprinosine」

Inosine pranobex
	IUPAC name 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one : 4-acetamidobenzoic acid : 1-(dimethylamino)propan-2-ol
	Other names Isoprinosine; Methisoprinol
Identifiers
CAS number	36703-88-5
PubChem	37510
ChemSpider	16736312
KEGG	D01995
ATC code	J05AX05
Jmol-3D images	Image 1
	SMILES CN(C)CC(C)O.OC(=O)c1ccc(NC(C)=O)cc1.Oc3ncnc2c3ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O ;
	InChI InChI=1/C10H12N4O5.C9H9NO3.C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;1-6(11)10-8-4-2-7(3-5-8)9(12)13;1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);2-5H,1H3,(H,10,11)(H,12,13);5,7H,4H2,1-3H3/t4-,6-,7-,10-;;/m0../s1; Key: PBJNZCQJMWVIRT-MDQYBHOLBR ;
Properties
Molecular formula	C52H78N10O17
Molar mass	1115.23 g/mol
	Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
	Infobox references